Cargando…
The Importance of Endpoints in Oncology Clinical Trials
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Harborside Press LLC
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558020/ https://www.ncbi.nlm.nih.gov/pubmed/37808074 http://dx.doi.org/10.6004/jadpro.2023.14.6.1 |
| _version_ | 1785117196175802368 |
|---|---|
| author | Faiman, Beth |
| author_facet | Faiman, Beth |
| author_sort | Faiman, Beth |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10558020 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Harborside Press LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105580202023-10-07 The Importance of Endpoints in Oncology Clinical Trials Faiman, Beth J Adv Pract Oncol Editorial Harborside Press LLC 2023-09 2023-09-01 /pmc/articles/PMC10558020/ /pubmed/37808074 http://dx.doi.org/10.6004/jadpro.2023.14.6.1 Text en © 2023 Harborside™ https://creativecommons.org/licenses/by-nc-nd/3.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial Non-Derivative License, which permits unrestricted non-commercial and non-derivative use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Faiman, Beth The Importance of Endpoints in Oncology Clinical Trials |
| title | The Importance of Endpoints in Oncology Clinical Trials |
| title_full | The Importance of Endpoints in Oncology Clinical Trials |
| title_fullStr | The Importance of Endpoints in Oncology Clinical Trials |
| title_full_unstemmed | The Importance of Endpoints in Oncology Clinical Trials |
| title_short | The Importance of Endpoints in Oncology Clinical Trials |
| title_sort | importance of endpoints in oncology clinical trials |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558020/ https://www.ncbi.nlm.nih.gov/pubmed/37808074 http://dx.doi.org/10.6004/jadpro.2023.14.6.1 |
| work_keys_str_mv | AT faimanbeth theimportanceofendpointsinoncologyclinicaltrials AT faimanbeth importanceofendpointsinoncologyclinicaltrials |